Dr. Shoag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3299
Education & Training
New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Minimally Invasive Urologic Surgery, 2018 - 2020
Weill CornellMS, Clinical and Translational Investigation, 2018 - 2020- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
- Massachusetts Institute of TechnologyHST, 2007 - 2012
Harvard Medical SchoolClass of 2012, MD, Magna cum Laude, Honors- University of PennsylvaniaBa, Biology, Summa cum Laude, phi beta kappa, 2003 - 2007
Certifications & Licensure
OH State Medical License 2020 - 2026
PA State Medical License 2024 - 2024
NY State Medical License 2019 - 2021- American Board of Urology Urology
Publications & Presentations
PubMed
- 40 citationsTransperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial.Jim C Hu, Melissa Assel, Mohamad E Allaf, Behfar Ehdaie, Andrew J Vickers
European Urology. 2024-07-01 - 37 citationsIntegrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.Deli Liu, Jonathan Shoag, Daniel Poliak, Ramy Goueli, Vaishali Ravikumar
Nature Communications. 2020-04-24 - 1 citationsUnderstanding the True Prevalence of Prostate Cancer Genomic Subtypes: Use of Inverse Probability Weighting to Correct for Biases in Molecularly Profiled Cohorts.Peter Y. Cai, Xiaoyue Ma, Paul Christos, Christopher E. Barbieri, Jonathan Shoag
The Journal of Urology. 2021-01-27
Journal Articles
- Reconsidering the Trade-Offs of Prostate Cancer ScreeningJonathan E Shoag, Jim C Hu, The New England Journal of Medicine
Authored Content
- Reconsidering the Trade-Offs of Prostate Cancer ScreeningJune 2020
Press Mentions
Active Surveillance in Prostate Cancer Is Growing: What It Is and in Which Patients It Is IndicatedApril 18th, 2023- More Men with Prostate Cancer Are Opting for Active SurveillanceApril 5th, 2023
- More U.S. Prostate Cancer Patients Choosing Active Surveillance over TreatmentApril 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
